MenQuadfi

Land: Europeiska unionen

Språk: finska

Källa: EMA (European Medicines Agency)

Aktiva substanser:

Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid

Tillgänglig från:

Sanofi Pasteur

ATC-kod:

J07AH08

INN (International namn):

meningococcal group A, C, W-135 and Y conjugate vaccine

Terapeutisk grupp:

rokotteet

Terapiområde:

Meningiitti, meningokokki

Terapeutiska indikationer:

MenQuadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. The use of this vaccine should be in accordance with available official recommendations.

Produktsammanfattning:

Revision: 8

Bemyndigande status:

valtuutettu

Tillstånd datum:

2020-11-18

Bipacksedel

504 GATEWAY TIME-OUT

Produktens egenskaper

504 GATEWAY TIME-OUT